4911
SGS742 in Patients With Mild to Moderate Alzheimer’s Disease (AD)
Condition(s):Alzheimer’s DiseaseLast Updated:December 11, 2009Completed
Aging: 5006 Clinical Trials, Page 492 of 501
Hide Studies Not Open or Pending
4912
Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson’s Disease.
Condition(s):Idiopathic Parkinson DiseaseLast Updated:May 3, 2019Terminated
4913
Dose Finding Study of Bone Morphogenetic Protein 7 (BMP-7) in Subjects With Osteoarthritis (OA) of the Knee
Condition(s):Osteoarthritis of the KneeLast Updated:February 1, 2012Completed
4914
Improving Communication for Primary Care Patients
Condition(s):Advance Care Planning; DementiaLast Updated:April 1, 2021Enrolling by invitation
4915
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
Condition(s):Alzheimer’s Disease; Stroke; Parkinson’s Disease; Traumatic Brain InjuryLast Updated:July 14, 2016Completed
4916
Group Exercise Training for Functional Improvement After Treatment (The GET FIT Trial)
Condition(s):Malignant Neoplasm; PostmenopausalLast Updated:July 29, 2020Completed
4917
Aromatase Inhibitors and Weight Loss in Severely Obese Men With Hypogonadism
Condition(s):Hypogonadism, Hypogonadotropic; ObesityLast Updated:January 14, 2021Recruiting
4918
WILSTIM – DBS (WILson STIMulation – Deep Brain Stimulation)
Condition(s):Severe Dystonia; Wilson’s DiseaseLast Updated:July 12, 2018Recruiting
4919
Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of “OFF” Episodes in Patients With Parkinson’s Disease
Condition(s):Parkinson DiseaseLast Updated:December 17, 2020Recruiting
4920
A Pilot Study to Evaluate the Lipid Effects of TRIA-662
Condition(s):Hypertriglyceridemia; Mixed HyperlipidemiaLast Updated:January 27, 2016Completed